Effect of Neural Mobilization on Lumbosacral Radiculopathy Patients With Peripheral Sensitization

February 28, 2023 updated by: Mohammed Al-Ghamdi

Effect of Neural Mobilization Techniques on Pain, and Hip and Knee Range of Motion on Lumbosacral Radiculopathy Patients With Peripheral Sensitization

The primary purpose of this study was to investigate the effects of slider and tensioner techniques on pain, hip and knee ROM in lumbosacral radiculopathy patients with peripheral sensitization. A secondary purpose was to evaluate the correlation between these outcomes measurements.

Study Overview

Detailed Description

Study design: Double-blind case-control trial. Methods: Fifty-one male lumbosacral radiculopathy patients with peripheral sensitization, were divided into one of the three groups: slider, tensioner, and control. The primary outcome measurements were visual analog scale (VAS) for pain, hip range of motion (ROM) during SLR test, and knee flexion ROM during slump test. The measurements were taken at baseline, after 1st, 3rd, and 6th session.

Statistical Analysis: A two-way mixed design analysis of variance (MANOVA) with post-hoc (Bonferonni Correction) was used to calculate the differences with Time (baseline, 1st,3rd,6th sessions) as a within-group factor and Group (control, slider, and tensioner) as a between-group factor. The effect size was calculated with Cohen's d. Pearson's correlation was used for correlation analysis.

Study Type

Interventional

Enrollment (Actual)

51

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 60 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Male

Description

Inclusion Criteria:

  • Patients with lumbosacral radiculopathy with dominant peripheral sensitization
  • patients with unilateral leg pain.
  • patient S-LANSS score > 12,
  • negative sensory and motor examination.
  • positive neural tissue provocation tests (straight leg raising test, slump test).
  • adult.
  • pain duration of more than 3 months.

Exclusion Criteria:

  • S-LANSS score ≥ 12,
  • motor or sensory deficits,
  • history of back or lower extremity surgeries,
  • bilateral referred pain,
  • patients with pacemakers, cardiovascular problems, epilepsy, active malignancy, dermatological conditions, and diminished pain sensation.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Control group
Patients in this group had 6 sessions in 2 weeks of Transcutaneous Electric Nerve Stimulation (TENS).
Electrotherapy device aiming to decrease patient's symptoms.
Other Names:
  • Control
Experimental: Tensioner Group
Patients in this group had 6 sessions in 2 weeks of TENS combined with neural mobilization exercises (Tensioner technique).
Exercise aiming to lengthen the neural structure using more than one joint.
Experimental: Slider Group
Patients in this group had 6 sessions in 2 weeks of TENS combined with neural mobilization exercises (Slider technique).
Exercise aiming to slide/glide the neural structure using more than one joint.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Visual Analog Scale
Time Frame: The measurements were taken at days "0,1,5,12"
Visual analog scale was used to measure pain intensity. This scale is a 10 cm line where patients chose from 0 to 10 (when 0 mean no pain and 10 mean maximum pain)
The measurements were taken at days "0,1,5,12"
Hip Flexion Range of Motion (Symptomatic Side)
Time Frame: The measurements were taken at days "0,1,5,12"
Change in Hip flexion range of motion during straight leg raising (symptomatic side)
The measurements were taken at days "0,1,5,12"
Knee Flexion Range of Motion (Symptomatic Side)
Time Frame: The measurements were taken at days "0,1,5,12"
Change in Knee flexion range of motion during slump (symptomatic side)
The measurements were taken at days "0,1,5,12"
Hip Flexion Range of Motion (Asymptomatic Side)
Time Frame: The measurements were taken at days "0,1,5,12"
Change in Hip Flexion Range of Motion During Straight Leg Raising (Asymptomatic Side)
The measurements were taken at days "0,1,5,12"
Knee Flexion Range of Motion (Asymptomatic Side)
Time Frame: The measurements were taken at days "0,1,5,12"
Change in Knee flexion range of motion during slump (Asymptomatic side)
The measurements were taken at days "0,1,5,12"

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 1, 2015

Primary Completion (Actual)

November 28, 2017

Study Completion (Actual)

March 30, 2018

Study Registration Dates

First Submitted

July 30, 2018

First Submitted That Met QC Criteria

August 8, 2018

First Posted (Actual)

August 9, 2018

Study Record Updates

Last Update Posted (Actual)

March 1, 2023

Last Update Submitted That Met QC Criteria

February 28, 2023

Last Verified

February 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Radiculopathy

Clinical Trials on Transcutaneous Electrical Nerve Stimulation (TENS)

3
Subscribe